Nureca [NURECA] vs Fischer Medical [FISCHER] Detailed Stock Comparison

Nureca

NSE
Loading...

Fischer Medical

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Nureca wins in 11 metrics, Fischer Medical wins in 7 metrics, with 0 ties. Nureca appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricNurecaFischer MedicalBetter
P/E Ratio (TTM)306.061,197.22Nureca
Price-to-Book Ratio1.1935.60Nureca
Debt-to-Equity Ratio2.5625.27Nureca
PEG Ratio-5.98-8.26Fischer Medical
EV/EBITDA-15.95849.13Nureca
Profit Margin (TTM)0.00%5.26%Fischer Medical
Operating Margin (TTM)-3.20%14.89%Fischer Medical
EBITDA Margin (TTM)N/A14.89%N/A
Return on Equity0.44%0.36%Nureca
Return on Assets (TTM)0.40%0.26%Nureca
Free Cash Flow (TTM)$-234.06M$-927.26MNureca
1-Year Return-25.08%59.80%Fischer Medical
Price-to-Sales Ratio (TTM)1.8855.67Nureca
Enterprise Value$1.12B$67.25BFischer Medical
EV/Revenue Ratio0.9153.58Nureca
Gross Profit Margin (TTM)35.11%45.56%Fischer Medical
Revenue per Share (TTM)$123$1Nureca
Earnings per Share (Diluted)$0.85$0.09Nureca
Beta (Stock Volatility)0.480.00Fischer Medical
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Nureca vs Fischer Medical Stock Performance Analysis

Loading Price Chart...

Nureca
Fischer Medical
Nureca Stock Overview | Fischer Medical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Nureca3.25%4.35%-5.25%-16.86%6.15%-16.19%
Fischer Medical-0.51%-5.37%-0.47%26.96%29.19%52.48%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Nureca-25.08%-74.01%-64.86%-64.86%-64.86%-64.86%
Fischer Medical59.80%893.99%3,779.06%1,435.00%-66.84%527.63%

News Based Sentiment: Nureca vs Fischer Medical

Nureca

News based Sentiment: NEGATIVE

September was a challenging month for Nureca, marked by strong revenue growth offset by a significant decline in profitability and waning investor confidence. While a 'BUY' rating offers some optimism, the overall narrative points to substantial risks and the need for a turnaround in financial performance.

View Nureca News Sentiment Analysis

Fischer Medical

News based Sentiment: POSITIVE

September was a remarkably positive month for Fischer Medical Ventures, driven by exceptional financial results, a successful listing on the NSE, and a shareholder-friendly stock split. These developments signal strong growth and investor confidence, making it a significant period for the company's investment story.

View Fischer Medical News Sentiment Analysis

Performance & Financial Health Analysis: Nureca vs Fischer Medical

MetricNURECAFISCHER
Market Information
Market Cap i₹2.32B₹69.68B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i14,96431,869
90 Day Avg. Volume i16,84846,259
Last Close₹238.28₹107.45
52 Week Range₹203.62 - ₹447.50₹60.01 - ₹124.20
% from 52W High-46.75%-13.49%
All-Time High₹2,315.00 (Oct 04, 2021)₹2,386.00 (Apr 21, 2008)
% from All-Time High-89.71%-95.50%
Growth Metrics
Quarterly Revenue Growth0.69%1.32%
Quarterly Earnings Growth-0.51%N/A
Financial Health
Profit Margin (TTM) i0.00%0.05%
Operating Margin (TTM) i-0.03%0.15%
Return on Equity (TTM) i0.00%0.00%
Debt to Equity (MRQ) i2.5625.27
Cash & Liquidity
Book Value per Share (MRQ)₹194.28₹3.03
Cash per Share (MRQ)₹123.05₹3.94
Operating Cash Flow (TTM) i₹-172,050,000₹-1,020,336,000
Levered Free Cash Flow (TTM) i₹8.46M₹12.08M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Nureca vs Fischer Medical

MetricNURECAFISCHER
Price Ratios
P/E Ratio (TTM) i306.061,197.22
Forward P/E iN/AN/A
PEG Ratio i-5.98-8.26
Price to Sales (TTM) i1.8855.67
Price to Book (MRQ) i1.1935.60
Market Capitalization
Market Capitalization i₹2.32B₹69.68B
Enterprise Value i₹1.12B₹67.25B
Enterprise Value Metrics
Enterprise to Revenue i0.9153.58
Enterprise to EBITDA i-15.95849.13
Risk & Other Metrics
Beta i0.480.00
Book Value per Share (MRQ) i₹194.28₹3.03

Financial Statements Comparison: Nureca vs Fischer Medical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)NURECAFISCHER
Revenue/Sales i₹341.76M₹234.45M
Cost of Goods Sold i₹221.78M₹127.64M
Gross Profit i₹119.98M₹106.81M
Research & Development iN/AN/A
Operating Income (EBIT) i₹-10.93M₹34.90M
EBITDA i₹20.11M₹117.28M
Pre-Tax Income i₹12.31M₹101.75M
Income Tax i₹4.18M₹51.67M
Net Income (Profit) i₹8.13M₹50.08M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)NURECAFISCHER
Cash & Equivalents i₹32.41M₹1.04B
Total Current Assets i₹1.90B₹3.65B
Total Current Liabilities i₹123.99M₹1.02B
Long-Term Debt i₹25.90M₹172.06M
Total Shareholders Equity i₹1.94B₹3.38B
Retained Earnings i₹868.20M₹29.05M
Property, Plant & Equipment i₹70.13M₹89.03M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)NURECAFISCHER
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNURECAFISCHER
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i14,96431,869
Average Daily Volume (90 Day) i16,84846,259
Shares Outstanding i10.00M638.02M
Float Shares i3.38M147.07M
% Held by Insiders i0.67%0.76%
% Held by Institutions i0.00%0.03%

Dividend Analysis & Yield Comparison: Nureca vs Fischer Medical

MetricNURECAFISCHER
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00N/A
Ex-Dividend DateN/AN/A